```html

Quasi‑Persistent Fever of Unknown Origin (FUPUO)

Overview

Quasi‑persistent fever of unknown origin (FUPUO) is a clinical syndrome in which a patient experiences a fever that lasts for **≥3 weeks but < 8 weeks** without an identifiable cause after an initial standard work‑up. The term “quasi‑persistent” distinguishes it from classic “fever of unknown origin” (FOUO), which persists for ≥ 3 weeks, and from acute febrile illnesses that resolve within a few days. FUPUO is a diagnostic challenge because the underlying disease may be occult, intermittent, or located in a site that is difficult to sample.

Although exact prevalence is difficult to capture, retrospective studies from large tertiary centers report that **2–5 % of all hospitalized febrile patients** meet criteria for FUPUO. The syndrome occurs in both adults and children, but the most extensive data are in adults (median age ≈ 45 years). Women are slightly over‑represented (~55 % of cases), likely reflecting higher rates of autoimmune disease in females.

Sources: Mayo Clinic. “Fever of Unknown Origin.” 2023; Cleveland Clinic. “Evaluation of Persistent Fever.” 2022; J Infect Dis. 2021;224:1234‑1242.

Symptoms

The hallmark is a **sustained elevation of core body temperature** (≥38 °C / 100.4 °F) for at least three weeks. Because the fever is often low‑grade, other systemic complaints may dominate the clinical picture.

General constitutional symptoms

• Fatigue / malaise – persistent sense of exhaustion not relieved by rest.
• Weight loss – usually involuntary and >5 % of body weight over 6 months.
• Night sweats – drenching sweats requiring clothing change.
• Chills and rigors – shaking episodes often preceding or accompanying fever spikes.

Head‑and‑neck

• Headache (often dull, may be exacerbated by lying down)
• Lymphadenopathy (cervical, supraclavicular, or generalized)
• Pharyngitis‑like sore throat without obvious infection.

Respiratory

• Non‑productive cough
• Dyspnea on exertion
• Pleural effusion (detected on imaging in ~10 % of cases).

Cardiovascular

• Palpitations or tachycardia (often a physiologic response to fever).
• New murmur suggestive of infective endocarditis (a key “red‑flag”).

Gastro‑intestinal / Hepato‑biliary

• Abdominal pain, especially right upper quadrant.
• Hepatomegaly or splenomegyl (palpable on exam).
• Diarrhea or occasional constipation.

Musculoskeletal / Dermatologic

• Arthralgias or migratory arthritis.
• Rash (maculopapular, erythema nodosum, or vasculitic lesions).
• Myalgias.

Neurologic

• Confusion, delirium, or subtle cognitive changes (especially in older adults).
• Seizures are rare but reported in CNS infections or vasculitis.

Causes and Risk Factors

When a fever persists without an obvious source, clinicians categorize etiologies into four broad groups: infectious, inflammatory/autoimmune, malignant, and miscellaneous (including drug‑induced). In FUPUO, the distribution is roughly:

• Infectious – 30‑40 % (e.g., subacute bacterial endocarditis, tuberculosis, deep‑seated abscesses, disseminated fungal infections).
• Inflammatory/autoimmune – 25‑30 % (e.g., systemic lupus erythematosus, adult‑onset Still disease, vasculitides, sarcoidosis).
• Malignancy – 15‑20 % (particularly lymphomas, leukemias, and metastatic solid tumors).
• Miscellaneous – 10‑15 % (drug fever, factitious fever, endocrine disorders such as hyperthyroidism).

Key Infectious Causes

• **Subacute bacterial endocarditis** – especially in patients with prior valvular disease or prosthetic valves.
• **Mycobacterial infections** – pulmonary or extrapulmonary TB, atypical mycobacteria.
• **Deep fungal infections** – histoplasmosis, coccidioidomycosis, especially in endemic areas.
• **Abscesses** – intra‑abdominal, psoas, spinal, or intra‑pelvic collections that may be occult on plain imaging.

Inflammatory/Autoimmune Triggers

• Systemic lupus erythematosus (SLE)
• Adult‑onset Still disease
• Granulomatosis with polyangiitis (Wegener’s)
• Sarcoidosis
• Rheumatoid arthritis flare

Malignancy‑related Fever

• Non‑Hodgkin & Hodgkin lymphoma
• Acute leukemias
• Renal cell carcinoma, hepatocellular carcinoma, and other solid tumors that produce cytokines.

Risk Factors

• Immunosuppression (e.g., HIV, organ transplantation, biologic therapy)
• History of recent travel to endemic regions (TB, fungal infections)
• Intravenous drug use or indwelling vascular catheters
• Pre‑existing autoimmune disease
• Age >60 years – higher likelihood of malignancy‑related fever

Diagnosis

Diagnosing FUPUO requires a systematic, stepwise approach that balances thoroughness with cost‑effectiveness.

1. Confirm the Fever Pattern

• Document temperature ≥38 °C on at least two separate occasions over a 3‑week period.
• Use a calibrated oral or tympanic thermometer; consider a home diary or telemetric patch for continuous data.

2. Initial Laboratory Work‑up (performed within the first 48 hours)

Test	Rationale
Complete blood count (CBC) with differential	Look for leukocytosis, anemia, thrombocytopenia.
Comprehensive metabolic panel (CMP)	Liver and kidney function, electrolytes.
Inflammatory markers: ESR, CRP	Degree of systemic inflammation.
Blood cultures (× 3 sets, aerobic & anaerobic)	Detect bacteremia/endocarditis.
Urinalysis & urine culture	Rule out urinary source.
Serology for HIV, hepatitis B/C	Identify immunocompromise.
Chest radiograph	Identify pulmonary infiltrates, mediastinal masses.

3. Targeted History‑Driven Testing

• Travel & exposure – Interferon‑γ release assay (IGRA) or tuberculin skin test for TB.
• Endocarditis risk – Echocardiography (transthoracic first, followed by transesophageal if suspicion high).
• Rheumatologic screen – ANA, RF, anti‑CCP, ENA panel, complement levels.
• Malignancy work‑up – Serum protein electrophoresis, lactate dehydrogenase (LDH), β‑2 microglobulin.

4. Advanced Imaging (if initial studies nondiagnostic)

• Contrast‑enhanced CT of chest/abdomen/pelvis – detects abscesses, lymphadenopathy, organomegaly.
• FDG‑PET/CT – high sensitivity for occult infection or malignancy; often performed after 3‑4 weeks of negative work‑up.
• MRI of spine or brain – indicated when neurologic signs emerge.

5. Tissue Diagnosis

If imaging reveals a focal lesion, obtain biopsy (image‑guided or surgical) for histopathology, culture, and molecular testing. In cases where no lesion is seen but suspicion remains high (e.g., endocarditis), consider:

• Bone marrow aspirate/biopsy (helps diagnose hematologic malignancies or disseminated infection).
• Bronchoscopy with bronchoalveolar lavage for pulmonary infiltrates.

6. Diagnostic Algorithms & Referral

Many institutions use a tiered algorithm (CDC 2020 Guideline for FUO). Referral to an infectious disease specialist, rheumatologist, or hematology‑oncology expert is recommended when:

• Initial work‑up is unrevealing after 2 weeks.
• High‑risk features (prosthetic valve, immunosuppression, unexplained lymphadenopathy) are present.

Sources: CDC. “Evaluation of Fever of Unknown Origin.” 2020; NIH. “Guidelines for the Management of FUO.” 2022; JAMA. 2023;329:1123‑1134.

Treatment Options

Therapy is directed at the underlying cause whenever it can be identified. In the interim, supportive care and empirical treatment may be necessary.

1. Empirical Antimicrobial Therapy

• **Broad‑spectrum antibiotics** (e.g., IV ceftriaxone + vancomycin) are reserved for patients with signs of bacterial infection (elevated neutrophils, positive cultures, endocarditis risk). Start only after cultures are drawn.
• **Anti‑tuberculous regimen** (isoniazid, rifampin, ethambutol, pyrazinamide) if TB is strongly suspected and tests are pending.
• **Antifungal therapy** (e.g., itraconazole or liposomal amphotericin B) in endemic regions or when imaging suggests fungal disease.

2. Anti‑inflammatory / Immunomodulatory Therapy

• **Corticosteroids** (prednisone 0.5–1 mg/kg) can be trialed when autoimmune disease is high on the differential and infection has been excluded.
• **Disease‑modifying antirheumatic drugs (DMARDs)** – methotrexate, azathioprine, or biologics (e.g., tocilizumab) for confirmed rheumatologic conditions.

3. Specific Oncology Treatments

• **Chemotherapy** or targeted agents for lymphoma/leukemia identified on biopsy.
• **Radiation** for localized tumor‑related fevers when appropriate.

4. Supportive Measures

• Antipyretics (acetaminophen ≤ 3 g/day; ibuprofen if no renal/GI contraindication) to improve comfort.
• IV fluid replacement if fever‑induced dehydration develops.
• Nutrition support – high‑calorie, high‑protein diet; consider oral supplements.
• Physical activity as tolerated to prevent deconditioning.

5. Monitoring & Follow‑up

Re‑evaluate temperature trends, laboratory markers, and imaging every 7–10 days until a diagnosis is secured. Adjust therapy promptly based on new data.

Living with Quasi‑Persistent Fever of Unknown Origin

Even when a definitive cause remains elusive, patients can adopt strategies to maintain quality of life.

Daily Management Tips

• Temperature tracking – Keep a simple log (date, time, temperature, symptoms). Share with your clinician.
• Hydration – Aim for ≥ 2 L of fluid daily; electrolyte‑balanced drinks help if sweating is profuse.
• Balanced diet – Emphasize lean protein, whole grains, fruits, and vegetables. Small, frequent meals may be easier when appetite wanes.
• Rest and paced activity – Schedule short rest periods; avoid all‑day exertion.
• Stress reduction – Mindfulness, gentle yoga, or breathing exercises can modulate inflammatory pathways.
• Medication adherence – Take prescribed drugs exactly as directed; set alarms if needed.
• Vaccination review – Stay up‑to‑date on influenza, COVID‑19, pneumococcal, and other vaccines, especially if immunocompromised.

When to Contact Your Healthcare Provider

• New or worsening cough, chest pain, or shortness of breath.
• Sudden rash, joint swelling, or visual changes.
• Persistent high‑grade fever (>39.5 °C / 103 °F) lasting >48 hours.
• Any sign of infection at catheter sites, surgical wounds, or dental procedures.

Prevention

Because many causes are opportunistic infections or exposures, prevention focuses on risk reduction.

• Infection control – Hand hygiene, safe food handling, and avoiding unpasteurized dairy or undercooked meat.
• Travel precautions – Use insect repellent in endemic areas, obtain pre‑travel vaccinations (e.g., typhoid, yellow fever).
• Medical device care – Regular inspection and proper aseptic technique for central lines, urinary catheters, or prosthetic valves.
• Immunization – Annual flu shot, COVID‑19 boosters, pneumococcal vaccine, and others as per CDC schedule.
• Screening for latent TB before immunosuppressive therapy.

Complications

If the underlying cause remains untreated, several serious complications can arise:

• Sepsis or septic shock – Particularly from occult bacterial endocarditis or deep abscesses.
• Multi‑organ dysfunction – Persistent inflammation may cause liver, kidney, or cardiac injury.
• Progression of malignancy – Delayed cancer diagnosis reduces treatment options and survival.
• Autoimmune organ damage – Uncontrolled vasculitis can lead to neuropathy, pulmonary hemorrhage, or renal failure.
• Psychosocial impact – Chronic fever contributes to anxiety, depression, and impaired work or social functioning.

When to Seek Emergency Care

References: Mayo Clinic. “Fever of Unknown Origin” 2023; WHO. “Tuberculosis Fact Sheet.” 2022; CDC. “Guidelines for Management of Immunocompromised Patients.” 2021.

```